STOCK TITAN

Federated Hermes sells 97,549 NERV shares (NASDAQ: NERV) in Form 144 notice

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Federated Hermes Kaufmann Small Cap Fund reported a sale of 97,549 shares of Common Stock of NERV on 03/10/2026 for $743,274.98. The filing also lists a prior entry showing 534,050 shares of Common Stock described as "Secondary Offering/Open Market" dated 04/15/2015 with Cash as the consideration type.

Positive

  • None.

Negative

  • None.

Insights

Notice of proposed and reported resale activity by an institutional holder; routine Form 144 disclosure.

Form 144s document intended or completed resales of restricted or control securities. This filing records a reported sale of $743,274.98 for 97,549 shares on 03/10/2026, consistent with an institutional resale.

Cash‑flow treatment is explicit for the reported trade; other line items (e.g., the 04/15/2015 entry for 534,050 shares) are listed as "Secondary Offering/Open Market" with Cash noted. Timing and broader dilution impact are not addressed in the excerpt.

Reported sale shares 97,549 shares sale by Federated Hermes Kaufmann Small Cap Fund on 03/10/2026
Proceeds from reported sale $743,274.98 cash consideration for the 97,549 shares on 03/10/2026
Listed secondary offering quantity 534,050 shares listed as "Secondary Offering/Open Market" dated 04/15/2015 with Cash
Form 144 regulatory
"Common Stock | 04/15/2015 | Secondary Offering/Open Market"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Secondary Offering/Open Market market
"Secondary Offering/Open Market | Unknown | | | 534050 | 04/15/2015 | Cash"
Common Stock financial
"Securities To Be Sold | Common Stock | 04/15/2015"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What did the Form 144 for NERV report?

The Form 144 reported a sale of 97,549 shares of NERV on 03/10/2026 for $743,274.98. The filing also lists a separate entry for 534,050 shares dated 04/15/2015 described as a secondary/open market offering.

Who sold NERV shares in the Form 144 filing?

The filing names Federated Hermes Kaufmann Small Cap Fund as the selling holder for the reported transaction of 97,549 shares on 03/10/2026. Broker/dealer and other parties are listed in the excerpt without additional transaction details.

How much cash was generated by the reported NERV sale?

The reported sale of 97,549 shares generated $743,274.98 in cash according to the filing for the transaction dated 03/10/2026. The excerpt shows "Cash" as the consideration type for the listed transactions.

Does this Form 144 disclose remaining holdings or dilution for NERV?

The excerpt does not provide explicit post‑transaction holdings or shares outstanding tied to these entries. It lists specific resale quantities and cash amounts but does not state remaining beneficial ownership or company dilution figures in the provided text.
Minerva Neurosci

NASDAQ:NERV

View NERV Stock Overview

NERV Rankings

NERV Latest News

NERV Latest SEC Filings

NERV Stock Data

260.73M
5.44M
Biotechnology
Pharmaceutical Preparations
Link
United States
BURLINGTON